Wildlife-microbiome interactions and disease: exploring opportunities for disease mitigation across ecological scales
Candace L. Williams
Andrés Mauricio Caraballo-Rodríguez
Celeste Allaband
Amir Zarrinpar
Rob Knight
Julia M. Gauglitz
Candace Williams
Williams Candace
/ Candace L. Williams
ORCID: 0000-0002-1711-1183
Dietary shifts affect the gastrointestinal microflora of the giant panda (Ailuropoda melanoleuca)
10.1111/j.1439-0396.2012.01299.x
Dietary Shifts May Trigger Dysbiosis and Mucous Stools in Giant Pandas (Ailuropoda melanoleuca)
10.3389/fmicb.2016.00661
A hormone priming regimen and hibernation affect oviposition in the boreal toad (Anaxyrus boreas boreas)
10.1016/j.theriogenology.2015.04.017
Dietary changes during weaning shape the gut microbiota of red pandas (Ailurus fulgens)
10.1093/conphys/cox075
Gut microbiota and phytoestrogen-associated infertility in southern white rhinoceros
10.1101/451757
Gut Microbiota and Phytoestrogen-Associated Infertility in Southern White Rhinoceros
10.1128/mBio.00311-19
Wildlife-microbiome interactions and disease: exploring opportunities for disease mitigation across ecological scales
10.1016/j.ddmod.2019.08.012
Reference data based insights expand understanding of human metabolomes
10.1101/2020.07.08.194159
Regulation of endocrine systems by the microbiome: Perspectives from comparative animal models
10.1016/j.ygcen.2020.113437
Using reproductive technologies to assess the development of secondary sexual characteristics, ovarian senescence and hermaphroditism in the endangered mountain yellow-legged frog Rana muscosa
10.1071/RD21029
Reference data-set driven metabolomics
10.21203/rs.3.rs-654519/v1
Julia Gauglitz
Gauglitz Julia
/ Julia M. Vraspir
ORCID: 0000-0003-3146-2489
Amphiphilic siderophore production by oil-associating microbes
10.1039/c4mt00047a
Microbial Tailoring of Acyl Peptidic Siderophores
10.1021/bi500266x
A suite of citrate-derived siderophores from a marine Vibrio species isolated following the Deepwater Horizon oil spill
10.1016/j.jinorgbio.2011.10.013
Optical Signatures of Dissolved Organic Matter Transformation in the Global Ocean
10.3389/fmars.2015.00118
Amino acid variability in the peptide composition of a suite of amphiphilic peptide siderophores from an open ocean Vibrio species
10.1007/s00775-013-0995-3
Identification of new members within suites of amphiphilic marine siderophores
10.1007/s10534-010-9378-1
Chemistry of Marine Ligands and Siderophores
10.1146/annurev.marine.010908.163712
Both Incubation Temperature and Posthatching Temperature Affect Swimming Performance and Morphology of Wood Frog Tadpoles ( Rana sylvatica )
10.1086/498182
Untargeted Mass Spectrometry-Based Metabolomics Tracks Molecular Changes in Raw and Processed Foods and Beverages
10.1101/347716
Untargeted Mass Spectrometry-Based Metabolomics Approach Unveils Molecular Changes in Raw and Processed Foods and Beverages
10.1016/j.foodchem.2019.125290
Metabolome-informed microbiome analysis refines metadata classifications and reveals unexpected medication transfer in captive cheetahs
10.1101/790063
Native Electrospray-based Metabolomics Enables the Detection of Metal-binding Compounds
10.1101/824888
A UHPLC-HRMS based metabolomics and chemoinformatics approach to chemically distinguish ‘super foods’ from a variety of plant-based foods
10.1016/j.foodchem.2019.126071
Active nitrogen fixation by Crocosphaera expands their niche despite the presence of ammonium – A case study
10.1038/s41598-019-51378-4
Quantifying Oxygen Management and Temperature and Light Dependencies of Nitrogen Fixation by Crocosphaera watsonii
10.1128/msphere.00531-19
Wildlife-microbiome interactions and disease: exploring opportunities for disease mitigation across ecological scales
10.1016/j.ddmod.2019.08.012
Chemically-informed Analyses of Metabolomics Mass Spectrometry Data with Qemistree
10.1101/2020.05.04.077636
Reference data based insights expand understanding of human metabolomes
10.1101/2020.07.08.194159
Mauricio Caraballo
Caraballo Mauricio
/ Mauricio Caraballo
/ Andres M Caraballo-Rodriguez
ORCID: 0000-0001-5499-2728
Amphotericin B as an inducer of griseofulvin-containing guttate in the endophytic fungus Xylaria cubensis FLe9
10.1007/s00049-017-0243-3
Molecular inter-kingdom interactions of endophytes isolated from Lychnophora ericoides
10.1038/s41598-017-05532-5
Expanding the Chemical Repertoire of the Endophyte Streptomyces albospinus RLe7 Reveals Amphotericin B as an Inducer of a Fungal Phenotype
10.1021/acs.jnatprod.6b00870
Endophytic Actinobacteria from the Brazilian Medicinal PlantLychnophora ericoidesMart. and the Biological Potential of Their Secondary Metabolites
10.1002/cbdv.201500225
Protocol for Community‐created Public MS/MS Reference Spectra Within the Global Natural Products Social Molecular Networking Infrastructure
10.1002/rcm.8725
Mass spectrometry searches using MASST
10.1038/s41587-019-0375-9
Cryptic Species Account for the Seemingly Idiosyncratic Secondary Metabolism of Sarcophyton glaucum Specimens Collected in Palau
10.1021/acs.jnatprod.9b01128
Untargeted mass spectrometry-based metabolomics approach unveils molecular changes in raw and processed foods and beverages
10.1016/j.foodchem.2019.125290
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
10.1038/s41587-019-0209-9
MolNetEnhancer: Enhanced Molecular Networks by Integrating Metabolome Mining and Annotation Tools
10.3390/metabo9070144
The extracellular matrix protects Bacillus subtilis colonies from Pseudomonas invasion and modulates plant co-colonization
10.1038/s41467-019-09944-x
Propagating annotations of molecular networks using in silico fragmentation
10.1371/journal.pcbi.1006089
Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking
10.1038/nbt.3597
Wildlife-microbiome interactions and disease: exploring opportunities for disease mitigation across ecological scales
10.1016/j.ddmod.2019.08.012
Chemical signaling involved in plant–microbe interactions
10.1039/c7cs00343a
A Convolutional Neural Network-Based Approach for the Rapid Characterization of Molecularly Diverse Natural Products
10.1021/jacs.9b13786
Amir Zarrinpar
Zarrinpar Amir
ORCID: 0000-0001-6423-5982
Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism.
10.1038/s41467-018-05336-9
Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease.
10.1053/j.gastro.2020.01.050
Targeting Dysbiosis for the Treatment of Liver Disease.
10.1055/s-0035-1571276
Human Skin, Oral, and Gut Microbiomes Predict Chronological Age.
10.1128/msystems.00630-19
Video Capsule Endoscopy in Patients with Chronic Abdominal Pain with or without Associated Symptoms: A Retrospective Study
10.1371/journal.pone.0126509
Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non‐alcoholic fatty liver disease
10.1111/apt.12084
Obesogenic Drugs and their Effects on Post-Laparoscopic Sleeve Gastrectomy Outcomes
10.1016/s0016-5085(17)30624-8
Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis.
10.1371/journal.pone.0195123
Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians.
10.1016/j.cgh.2018.09.017
The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: a retrospective cohort study.
10.1038/s41366-018-0207-x
Sa1907 TIME OF COLLECTION IS CRITICAL TO REPRODUCIBILITY OF MICROBIOME RESULTS IN A MURINE MODEL OF DYSMETABOLISM
10.1016/s0016-5085(20)31866-7
Sa1915 – Altered Circadian Rhythm Cycling of Microbes and Metabolites in a Murine Model of Sleep Apnea
10.1016/s0016-5085(19)37981-8
803 Diet and Time Restricted Feeding Modulate Cyclical Changes in the Gut Microbiome and Can Affect Metabolic Homeostasis Through Bile Acid Signaling
10.1016/s0016-5085(14)60497-2
Psychiatry and stigmatization
10.1001/jama.287.14.1856-jms0410-2-1
Effect of Obesogenic Medications on Weight-Loss Outcomes in a Behavioral Weight-Management Program.
10.1002/oby.22444
Mo1553 Serum microRNA Profiling Differentiates NASH and Advanced Fibrosis in Well-Characterized Patients with Biopsy-Proven NAFLD
10.1016/s0016-5085(16)33857-4
Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial.
10.1038/ajg.2016.500
MSJAMA. Roles for medical students in the political process.
10.1001/jama.290.13.1774-b
Sa1877 - Access to Obesity Care for Patients Referred to an Established Weight-Management Program
10.1016/s0016-5085(18)31700-1
Differences in Weight Loss Between Persons on Standard Balanced vs Nutrigenetic Diets in a Randomized Controlled Trial.
10.1016/j.cgh.2015.02.044
381 The AspireAssist Is an Effective Tool in the Treatment of Class II and Class III Obesity: Results of a One-Year Clinical Trial
10.1016/s0016-5085(16)30406-1
Su1879 - High Body Mass Index is Associated with Increased Risk of Treatment Failure and Surgery in Biologic-Treated Patients with Ulcerative Colitis
10.1016/s0016-5085(18)32225-x
Time-Restricted Feeding Is a Preventative and Therapeutic Intervention against Diverse Nutritional Challenges
10.1016/j.cmet.2014.11.001
350 – Gwas-Identified Metabolic Syndrome Genes are Tightly Linked to Race
10.1016/s0016-5085(19)36962-8
Aspiration Therapy for the Treatment of Obesity: 2-4 Year Results of the PATHWAY Multicenter Randomized Controlled Trial
10.1016/j.soard.2018.09.018
36 Nutrigenetic-Guided Dietary Intervention and Weight Loss: A Randomized Controlled Feasibility Trial
10.1016/s0016-5085(15)30036-6
Do separate processes identify objects as exemplars versus members of basic-level categories? Evidence from hemispheric specialization.
10.1016/s0278-2626(03)00184-2
Characteristics of Non-Diagnostic Capsule Studies Due to a Fast Small Bowel Transit Time: 326
10.14309/00000434-201310001-00326
Diet and Feeding Pattern Affect the Diurnal Dynamics of the Gut Microbiome
10.1016/j.cmet.2014.11.008
Daily Eating Patterns and Their Impact on Health and Disease.
10.1016/j.tem.2015.11.007
MSJAMA. Quarantine.
10.1001/jama.290.21.2872
130 A MURINE MODEL OF OBSTRUCTIVE SLEEP APNEA REVEALS EARLY MARKERS OF DYSMETABOLISM IN THE GUT MICROBIOME AND METABOLOME
10.1016/s0016-5085(20)30744-7
Pre-Morbid Obesity is Associated with Increased Risk of Developing Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis
10.1016/s0016-5085(17)33310-3
The circadian coordination of cell biology.
10.1083/jcb.201603076
Obesity is Associated with Inferior Response to Anti-TNF Therapy in Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis
10.1016/s0016-5085(17)30838-7
Roles for Medical Students in the Political Process
10.1001/jama.290.13.1774-a
24 HIGHER BODY MASS INDEX IS ASSOCIATED WITH INCREASED RISK OF TREATMENT FAILURE AND SURGERY IN BIOLOGIC-TREATED PATIENTS WITH ULCERATIVE COLITIS
10.1093/ibd/izy038.020
24 HIGHER BODY MASS INDEX IS ASSOCIATED WITH INCREASED RISK OF TREATMENT FAILURE AND SURGERY IN BIOLOGIC-TREATED PATIENTS WITH ULCERATIVE COLITIS
10.1053/j.gastro.2017.11.241
52 Temporally Restricted Feeding Prevents Obesity and Other Metabolic Disorders Associated With High Fat Diet in Mice
10.1016/s0016-5085(12)60052-3
Association of Obesity with IBD Disease Location, Severity, and Treatment Course: A Single-Center Cohort Study
10.1016/s0016-5085(17)31507-x
Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial
10.1016/j.soard.2019.04.026
135 microRNAs Explain the Discordance of Nonalcoholic Fatty Liver Disease in Monozygotic and Dizygotic Twins: A Prospective Human Twin Study
10.1016/s0016-5085(15)30124-4
Sa1884 - Outcomes of a Behavioral Weight-Management Program is Affected by Physician-Prescribed Obesogenic Medications
10.1016/s0016-5085(18)31707-4
The effects of time-restricted feeding on lipid metabolism and adiposity.
10.1080/21623945.2015.1025184
High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis
10.1111/apt.14665
Su1977 Genetic Predictors of Weight Loss From a Behavior Modification Therapy
10.1016/s0016-5085(16)32075-3
Diagnostic Yield of Small-Bowel Capsule Endoscopy in Patients with Chronic Abdominal Pain: A Single-center Assessment: 327
10.14309/00000434-201310001-00327
1009 ALTERED DIURNAL FEEDING PATTERNS LINKED WITH HEPATIC, INTESTINAL, AND MICROBIOME CIRCADIAN DYSSYNCHRONY IN AGERELATED DYSMETABOLISM
10.1016/s0016-5085(20)31185-9
Sa1749 Can Gastric Transit Time From Video Capsule Endoscopy Be Used to Diagnose Gastroparesis? Within-Patient Precision and Comparison to Gastric Emptying Scintigraphy
10.1016/j.gie.2012.04.269
1012 DIET AND FEEDING PATTERN AFFECT THE TERMINAL ILEUM MICROBIOME AND TRANSCRIPTOME CIRCADIAN DYNAMICS
10.1016/s0016-5085(20)31188-4
Su2005 – Age-Related Dysmetabolism is Associated with Changes in Luminal Microbiome Dynamics
10.1016/s0016-5085(19)38639-1
A Rare Cause of an Ileocecal Fistula in an AIDS Patient
10.1053/j.gastro.2012.11.030
Sa1366 ANKK1 Predicts Improvement in Lipid Profile, Glycemic Control, and Favorable Changes in TFEQ Score in Participants Engaged in a Dietary and Lifestyle Modification Program
10.1016/s0016-5085(14)60968-9
Local connections to specific types of layer 6 neurons in the rat visual cortex
10.1152/jn.00974.2005
Functional Local Input to Layer 5 Pyramidal Neurons in the Rat Visual Cortex
10.1093/cercor/bhu268
Time-Restricted Feeding without Reducing Caloric Intake Prevents Metabolic Diseases in Mice Fed a High-Fat Diet
10.1016/j.cmet.2012.04.019
Effects of depression on sensory/motor vs. central processing in visual mental imagery
10.1080/02699930500405600
Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study
10.1136/gutjnl-2015-309456
Gut Microbiota and Their Influence on Response to Food
10.1016/b978-0-12-804572-5.00056-2
Sa1873 - Genetic Polymorphisms Related to Cholesterol Metabolism Predict Response to a Behavioral Weight Loss Program
10.1016/s0016-5085(18)31696-2
Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes
10.1038/nrgastro.2016.181
Wildlife-microbiome interactions and disease: exploring opportunities for disease mitigation across ecological scales
10.1016/j.ddmod.2019.08.012
